ARKG vs. CNCR ETF Comparison
Comparison of ARK Genomic Revolution Multi-Sector ETF (ARKG) to Loncar Cancer Immunotherapy ETF (CNCR)
ARKG
ARK Genomic Revolution Multi-Sector ETF
ARKG Description
Companies within ARKG are focused on and are expected to substantially benefit from extending and enhancing the quality of human and other life by incorporating technological and scientific developments and advancements in genomics into their business. The companies held in ARKG may develop, produce or enable: CRISPR Targeted Therapeutics Bioinformatics Molecular Diagnostics Stem Cells Agricultural Biology ARKG will be concentrated in issuers in any industry or group of industries in the health care sector, including issuers having their principal business activities in the biotechnology industry. ARKG is an actively managed ETF that seeks long-term growth of capital by investing under normal circumstances primarily (at least 80% of its assets) in domestic and foreign equity securities of companies across multiple sectors, including health care, information technology, materials, energy and consumer discretionary, that are relevant to the Fund’s investment theme of the genomics revolution.
Grade (RS Rating)
Last Trade
$23.22
Average Daily Volume
2,215,896
34
CNCR
Loncar Cancer Immunotherapy ETF
CNCR Description
ETF Series Solutions - Loncar Cancer Immunotherapy ETF is an exchange traded fund launched by ETF Series Solutions. The fund is co-managed by Exchange Traded Concepts, LLC and Vident Investment Advisory, LLC. It invests in public equity markets of the United States. The fund invests in stocks of companies operating in the pharmaceutical or biotechnology sectors, including those companies identified as having a high strategic focus on the development of drugs that harness the body's own immune system to fight cancer. It invests in stocks of companies across all market capitalizations. The fund seeks to replicate the performance of the Loncar Cancer Immunotherapy Index, by investing in stocks of companies as per their weightings in the index. ETF Series Solutions - Loncar Cancer Immunotherapy ETF is domiciled in the United States.Grade (RS Rating)
Last Trade
$13.22
Average Daily Volume
3,744
67
Performance
| Period | ARKG | CNCR |
|---|---|---|
| 30 Days | -3.53% | -13.14% |
| 60 Days | -11.54% | -15.74% |
| 90 Days | -13.90% | -11.75% |
| 12 Months | -15.87% | 25.96% |
ARKG Overweight 29 Positions Relative to CNCR
| Symbol | Grade | Weight | |
|---|---|---|---|
| TWST | F | 8.37% | |
| CRSP | D | 7.34% | |
| ADPT | C | 5.03% | |
| CDNA | D | 4.77% | |
| VCYT | B | 4.51% | |
| BEAM | D | 4.01% | |
| NTLA | F | 3.89% | |
| IONS | F | 3.85% | |
| NTRA | A | 3.82% | |
| TXG | F | 3.56% | |
| GH | B | 3.49% | |
| ARCT | F | 3.19% | |
| PSNL | D | 2.7% | |
| ABSI | F | 2.19% | |
| PACB | F | 2.16% | |
| BFLY | B | 1.71% | |
| VEEV | C | 1.7% | |
| AMGN | F | 1.68% | |
| ACCD | D | 1.47% | |
| VRTX | D | 1.29% | |
| ILMN | C | 1.25% | |
| CERS | D | 1.18% | |
| INCY | C | 1.11% | |
| PRME | F | 0.9% | |
| CMPS | F | 0.75% | |
| MASS | F | 0.69% | |
| QSI | C | 0.68% | |
| EXAS | D | 0.65% | |
| MRNA | F | 0.01% |
ARKG Underweight 62 Positions Relative to CNCR
| Symbol | Grade | Weight | |
|---|---|---|---|
| GLUE | C | -2.03% | |
| EXEL | B | -1.9% | |
| RVMD | C | -1.84% | |
| ACLX | C | -1.73% | |
| BMY | B | -1.72% | |
| ELVN | D | -1.68% | |
| XNCR | B | -1.66% | |
| MRSN | D | -1.62% | |
| BPMC | B | -1.58% | |
| KPTI | D | -1.57% | |
| REPL | D | -1.56% | |
| GNLX | F | -1.56% | |
| MGNX | F | -1.55% | |
| HCM | D | -1.54% | |
| SWTX | C | -1.47% | |
| CRBU | D | -1.47% | |
| JANX | C | -1.46% | |
| ERAS | C | -1.46% | |
| DAWN | D | -1.44% | |
| IMCR | D | -1.42% | |
| ARVN | F | -1.39% | |
| AURA | C | -1.38% | |
| LYEL | F | -1.35% | |
| SNDX | F | -1.34% | |
| MRUS | F | -1.33% | |
| KYMR | D | -1.32% | |
| GERN | D | -1.31% | |
| IOVA | F | -1.3% | |
| RCUS | F | -1.29% | |
| FHTX | C | -1.26% | |
| NUVB | C | -1.26% | |
| BNTX | C | -1.25% | |
| ZNTL | F | -1.25% | |
| MRK | D | -1.24% | |
| BCYC | F | -1.24% | |
| YMAB | F | -1.24% | |
| BMEA | F | -1.22% | |
| PGEN | F | -1.2% | |
| CGEM | F | -1.2% | |
| ALLO | F | -1.18% | |
| NUVL | C | -1.18% | |
| VOR | D | -1.17% | |
| GMAB | F | -1.17% | |
| TYRA | F | -1.16% | |
| KURA | F | -1.16% | |
| ACRV | F | -1.15% | |
| AUTL | F | -1.13% | |
| STRO | F | -1.12% | |
| LEGN | D | -1.1% | |
| IDYA | F | -1.07% | |
| TSVT | F | -1.06% | |
| ITOS | F | -0.98% | |
| IPHA | D | -0.98% | |
| SMMT | D | -0.97% | |
| ACET | F | -0.97% | |
| IMRX | F | -0.95% | |
| IMTX | F | -0.93% | |
| RLAY | F | -0.91% | |
| IGMS | F | -0.88% | |
| RAPT | F | -0.88% | |
| FATE | F | -0.87% | |
| PRLD | F | -0.55% |
ARKG: Top Represented Industries & Keywords
CNCR: Top Represented Industries & Keywords
Compare ETFs
